Predictive Character Analysis of Ganglionic Echography for the Diagnostic of Benin or Malignant Superficial Adenopathy
NCT ID: NCT02645825
Last Updated: 2016-07-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2016-05-31
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Echography examination should be a guide to take in charge the adenopathy and to predict presence of malignant (primitive) or benin (reactional) character of adenopathy. The aim of this study is to codify the management of adenopathic patient with a diagnostic in 48 hours after examination. This fast diagnostic helps to prevent unnecessary biopsy, to avoid wasting time in case of a serious pathology.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study
NCT06284980
Predicting Malignancy Using Endoluminal Ultrasound Characteristics in Mediastinal Lymph Nodes
NCT01329575
Description of Bullous Emphysema Using Lung Ultrasound and Comparison to the Characteristics of Pneumothorax
NCT04012359
Role of Color Doppler Ultrasound in Lymphadenopathy
NCT03760094
Evolution of Indications for Transbronchial Ganglionic Ultrasound
NCT03132883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Brest
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Christian Berthou
Role: PRINCIPAL_INVESTIGATOR
CHRU de Brest
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cabinet Brest
Brest, , France
Cabinet Brest
Brest, , France
Cabinet Brest
Brest, , France
Caninet Brest Centre
Brest, , France
CHRU de Brest
Brest, , France
Cabinet Ergue Gaberic
Ergue Gaberit, , France
Cabinet Ergue Gaberit
Ergue Gaberit, , France
Cabinet Ergue Gaberic
Ergué-Gabéric, , France
Cabine Le Guivinec
Guilvinec, , France
Cabinet Le Guilvinec
Guilvinec, , France
Cabinet Le Guilvinec
Guilvinec, , France
Cabinet Lamneur
Lanmeur, , France
Cabinet Lanmeur
Lanmeur, , France
Cabinet Lanmeur
Lanmeur, , France
Cabinet Lanmeur
Lanmeur, , France
Cabinet Lanmeur
Lanmeur, , France
Cabinet Brest Centre
Le Relecq-Kerhuon, , France
Cabinet Lesconil
Lesconil, , France
Cabinet Penmarch
Penmarch, , France
Cabinet Plouegat Guerrand
Plouegat Guerrand, , France
Cabinet Quimper
Quimper, , France
CHIC Quimper
Quimper, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Patrick Balouet
Role: primary
Eric Furet
Role: primary
Dominique Nerriec
Role: primary
Pierre Barraine
Role: primary
Stéphane Primault
Role: primary
Jean-François Velly
Role: primary
Gilles De Chazal
Role: primary
Bernard Le Floch
Role: primary
Denis Barda
Role: primary
Dominique Le Bail
Role: primary
Jean-Yves Reste
Role: primary
Fabien Huiban
Role: primary
Joël Le Roc'h
Role: primary
Lise Le Roc'h-Gestin
Role: primary
Emilie Beck-Robert
Role: primary
Benoît Chiron
Role: primary
Jean-Jérôme Le Coq
Role: primary
Jannick Saliou
Role: primary
Daniel Le Floc'h
Role: primary
Nikan Mohtadi
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EGAS - RB 14.077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.